Skip to main content

Select Drug Profiles

Practice Management

The Economic Burden of Fragile X Syndrome: Healthcare Resource Utilization in the United States

Patricia Sacco, MPH, RPh, Gorana Capkun-Niggli, PhD, Xin Zhang, MS, Rosemary Jose, PhD, Michael F. Murphy, MD, PhD

Stakeholder Perspective

Rarity, Disease Heterogeneity, and a Pathway for Estimating Economic Burden

The National Burden of Preventable Adverse Drug Events Associated with Inpatient Injectable Medications

Jeffrey M. Rothschild, MD, MPH, Bruce S. Pyenson, FSA, MAAA

Analyzing the Medtech Industry: A Predictive Tool in Healthcare

David B. Nash, MD, MBA

Achieving glucose, blood pressure, and lipid targets improving among diabetic patients, but there’s still long way to go

Payer Perspective: Reimbursement Obstacles Prevent Effective Treatment of Rosacea

Caroline Helwick

Rosacea Management: A Conversation with Dr Guy Webster

Caroline Helwick

Cardiometabolic Health

Cardiovascular data confirm metformin over sulfonylurea as initial treatment choice in type 2 diabetes

Does insulin increase the risk of type 2 diabetes-related complications?

Anti-Inflammatory–Dose Doxycycline Is Equally Effective in Men and Women with Rosacea

Caroline Helwick

Genomic Testing and the Quality of Care: Exploring the Impact of Healthcare Reform

John Hornberger, MD, MS, William J. Gradishar, MD, FACP, Barry V. Fortner, PhD, Matthew R.G. Taylor, MD, PhD, Bryan Loy, MD

Page 181 of 244
Results 1801 - 1810 of 2434